Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers, Aged”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05871541
What this trial is testing

A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine

Who this might be right for
Herpes Zoster (HZ)ShinglesInfectious Disease
Immorna Biotherapeutics, Inc. 75
Large-scale testing (Phase 3)Active Not RecruitingNCT05993325
What this trial is testing

Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers

Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 4,000
Early research (Phase 1)Ended earlyNCT00827489
What this trial is testing

Study Evaluating HTC-867 in Healthy Young and Elderly Subjects

Who this might be right for
Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer 72
Early research (Phase 1)Study completedNCT00896558
What this trial is testing

A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 52
Not applicableNot Yet RecruitingNCT07330960
What this trial is testing

Augmenting Existing Normative Data for QbMobile in Healthy Children Aged 6-11 Years

Who this might be right for
Healthy Volunteer
Qbtech AB 150
Testing effectiveness (Phase 2)Study completedNCT00356369
What this trial is testing

Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Early research (Phase 1)Study completedNCT02793232
What this trial is testing

Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.

Who this might be right for
Healthy Subjects
Pfizer 46
Testing effectiveness (Phase 2)Study completedNCT05060887
What this trial is testing

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

Who this might be right for
Influenza
Osivax 239
Early research (Phase 1)Study completedNCT00948662
What this trial is testing

Study Evaluating The Safety And Tolerability Of Administration Of Single Oral Doses Of SAM-760 To Healthy Subjects

Who this might be right for
Healthy
Pfizer 124
Testing effectiveness (Phase 2)Study completedNCT05975099
What this trial is testing

Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age

Who this might be right for
Lyme Disease
ModernaTX, Inc. 807
Testing effectiveness (Phase 2)Study completedNCT00880893
What this trial is testing

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Virus+1 more
Sanofi Pasteur, a Sanofi Company 1,198
Large-scale testing (Phase 3)Study completedNCT00464672
What this trial is testing

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Who this might be right for
Influenza
Novartis 1,893
Large-scale testing (Phase 3)Study completedNCT04440163
What this trial is testing

MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

Who this might be right for
Meningococcal Vaccine
Pfizer 2,431
Large-scale testing (Phase 3)Study completedNCT04713553
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 1,574
Large-scale testing (Phase 3)UnknownNCT05726084
What this trial is testing

Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older

Who this might be right for
COVID-19Coronavirus InfectionsRespiratory Tract Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 16,304
Large-scale testing (Phase 3)Study completedNCT02141516
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

Who this might be right for
Meningococcal Disease
Novartis 239
Early research (Phase 1)Study completedNCT02005211
What this trial is testing

A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers

Who this might be right for
Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
AstraZeneca 114
Early research (Phase 1)Study completedNCT01655771
What this trial is testing

TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects

Who this might be right for
Constipation
Glycyx Therapeutics 47
Not applicableStudy completedNCT04482530
What this trial is testing

Food Matrices Based on Fruit Pastes as Vectors of Carbohydrates for the Prevention and Management of Protein-energy Undernutrition in the Elderly (Fruisenior)

Who this might be right for
Healthy
University Hospital, Clermont-Ferrand 15
Early research (Phase 1)Study completedNCT01253499
What this trial is testing

Multiple Dose Study of TRx0037

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 31
Next Page